Quantcast
Last updated on April 18, 2014 at 7:49 EDT

Latest Astellas Pharma US Inc. Stories

2009-10-26 08:00:00

DEERFIELD, Ill., Oct. 26 /PRNewswire/ -- On November 1, 1999 Chicago Bears fans and the organ donation community experienced a great loss with the passing of Chicago Bears legend and organ donation advocate, Walter Payton. Payton, who suffered from primary sclerosing cholangitis, a rare autoimmune liver disease, passed away at the age of 45 while on the waiting list for a liver transplant. In honor of Payton, Donate Life Illinois (DLI) and Astellas Pharma US, Inc., (Astellas) in...

2009-10-22 07:30:00

SAN DIEGO and DEERFIELD, Ill., Oct. 22 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, and Astellas Pharma US, Inc. ("Astellas") announced that positive results from two clinical studies of new SUMAVEL DosePro (sumatriptan injection) needle-free delivery system will be published in the November 2009 issue of Headache. SUMAVEL DosePro, was recently approved by the FDA to treat acute migraine, with or without aura, and cluster headache. SUMAVEL DosePro...

2009-09-22 08:00:00

DEERFIELD, Ill., Sept. 22 /PRNewswire/ -- Astellas Pharma US, Inc. has announced the winners of the first annual Astellas Transplant Scholars Awards, $5,000 educational scholarships awarded to six transplant recipients. Entrants were asked to write an essay about how transplant affected their education plans, and how they would like to honor the gift of life they received by pursuing further education and giving back to the transplant community. "The Astellas Transplant Scholars Awards...

2009-09-21 09:03:00

DEERFIELD, Ill., Sept. 21 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy. The national, year-long program connects new science teachers to a range of tools and resources, while providing the support needed to build a strong foundation for science in their classrooms. The 2009...

2009-08-17 12:44:00

DEERFIELD, Ill., Aug. 17 /PRNewswire/ -- Chicago Mayor Richard M. Daley honored Astellas Pharma US, Inc. and two other Chicagoland companies on Aug. 14 at a ceremony in downtown Chicago with an award for their exemplary learning and development practices. The award and the event are sponsored each year by WorkforceChicago, which recognizes Chicagoland companies with exceptional learning and development programs. "Learning is the oxygen that breathes life into every successful...

2009-08-12 18:35:00

DEERFIELD, Ill., Aug. 12 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's (FDA) decision regarding its Citizen Petition. The company's requests have been denied by the U.S. District Court in Washington, D.C. The company is disappointed in the court's decision and is currently evaluating its next course of action. The Citizen...

2009-08-11 14:19:00

DEERFIELD, Ill., Aug. 11 /PRNewswire/ -- In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association for Business Resources (NABR). Astellas scored high in all 10 categories and was specifically recognized for the high level of employees' engagement and pride in the company. "At Astellas, we understand that investment in our employees is vital to...

2009-08-10 22:52:00

DEERFIELD, Ill., Aug. 10 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today that the U.S. Food and Drug Administration (FDA) has substantially denied the company's Citizen Petition to ensure the safe and effective use of immunosuppressants (also called anti-rejection medications) used to prevent rejection in organ transplant patients. In their petition, Astellas requested that the FDA take additional measures to protect transplant recipients, a unique and vulnerable...

2009-08-10 18:45:00

NASDAQ: CRME TSX: COM VANCOUVER and DEERFIELD, IL, Aug. 10 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by...

2009-08-03 07:52:00

SAN DIEGO and DEERFIELD, Ill., August 3 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company and Astellas Pharma US, Inc. ("Astellas"), announced today their exclusive co-promotion agreement for Sumavel DosePro (sumatriptan injection) needle-free delivery system. Sumavel DosePro received FDA approval in July 2009 and is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for...